<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92528">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02059954</url>
  </required_header>
  <id_info>
    <org_study_id>26-122 ex 13/14</org_study_id>
    <secondary_id>MUG 26-122 ex 13/14</secondary_id>
    <nct_id>NCT02059954</nct_id>
  </id_info>
  <brief_title>Vaginal vs. Laparoscopic Hysterectomy</brief_title>
  <official_title>Vaginal Hysterectomy Versus Total Laparoscopic Hysterectomy for Benign Indications: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Austrian Urogynecology Working Group (AUWG)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hysterectomy for benign indication is one of the most common surgical procedures in women.
      Numerous reviews and guidelines recommend the vaginal approach for benign hysterectomy, but
      the proportion of laparoscopic (and robotic) hysterectomies is increasing.

      This study will compare a range of clinical and subjective outcomes of vaginal vs. total
      laparoscopic hysterectomy. Outcomes include operating time, postoperative recovery, return
      to work as well as cosmesis, quality of life and sexual health.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Operating time (min.)</measure>
    <time_frame>Surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Operating time (min.)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Intraoperative and postoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia time (min.)</measure>
    <time_frame>surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual health</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to work</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Uterine Fibroids</condition>
  <condition>Uterine Leiomyoma</condition>
  <condition>Abnormal Uterine Bleeding, Unspecified</condition>
  <arm_group>
    <arm_group_label>Vaginal hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vaginal hysterectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total laparoscopic hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysterectomy</intervention_name>
    <arm_group_label>Vaginal hysterectomy</arm_group_label>
    <arm_group_label>Total laparoscopic hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  benign indication for vaginal hysterectomy (e.g., abnormal uterine bleeding,
             fibroids, atypical endometrial hyperplasia)

          -  clinical exam indicates vaginal hysterectomy is feasible

          -  no major concomitant surgery

          -  able to complete questionnaires in German

        Exclusion Criteria:

          -  uterine malignancy

          -  major concomitant surgery (e.g., for incontinence or prolapse)

          -  clinical exam indicating vaginal hysterectomy not feasible

          -  contraindication for surgery or laparoscopy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl F Tamussino, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rene W Laky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karl F Tamussino, MD</last_name>
    <phone>+43 316 385</phone>
    <phone_ext>12201</phone_ext>
    <email>karl.tamussino@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rene W Laky, MD</last_name>
    <phone>+43 316 385</phone>
    <phone_ext>12201</phone_ext>
    <email>rene.laky@klinikum-graz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Graz/Dept. OB/GYN</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl F Tamussino, MD</last_name>
      <phone>+43 316 385</phone>
      <phone_ext>12201</phone_ext>
      <email>karl.tamussino@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Rene W Laky, MD</last_name>
      <phone>+43 316 385</phone>
      <phone_ext>12201</phone_ext>
      <email>rene.laky@klinikum-graz.at</email>
    </contact_backup>
    <investigator>
      <last_name>Rene W Laky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brüder, Abteilung Gynäkologie</name>
      <address>
        <city>Graz</city>
        <zip>8020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter FJ Lang, MD</last_name>
      <phone>+43 316 7067</phone>
      <phone_ext>3102</phone_ext>
      <email>peter.lang@bbgraz.at</email>
    </contact>
    <investigator>
      <last_name>Peter FJ Lang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LKH Leoben/Abteilung Gynäkologie</name>
      <address>
        <city>Leoben</city>
        <zip>8700</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>George Ralph, MD</last_name>
      <phone>+43 3842 401</phone>
      <phone_ext>2382</phone_ext>
      <email>george.ralph@lkh-leoben.at</email>
    </contact>
    <investigator>
      <last_name>George Ralph, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 18, 2014</lastchanged_date>
  <firstreceived_date>February 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hysterectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
